Evotec combines over three decades of neuroscience innovation with cutting-edge technologies to accelerate the discovery and development of new therapies for epilepsy. Our fully integrated platform spans from target validation through IND-enabling studies, offering deep expertise in electrophysiology, ion channel biology, and translational seizure models.

By uniting in vitro, ex vivo, and in vivo systems with molecular patient data and multi-omics analytics, Evotec delivers actionable insights that bridge preclinical findings to clinical outcomes. Whether advancing small molecules, peptides, RNA therapeutics, or other modalities, our collaborative and flexible approach empowers partners to de-risk and accelerate their epilepsy R&D programs.

Download our Service Sheet to explore Evotec’s end-to-end capabilities in epilepsy research